Daré Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.52	24.71	15.7	10.48	34.67	51.67
Cash & Short-Term Investments	18.52	24.71	15.7	10.48	34.67	51.67
Cash Growth	79.28%	57.42%	49.85%	-69.78%	-32.91%	1006.64%
Other Receivables	0.69	-	-	0.95	1.7	1.15
Total Trade Receivables	0.69	-	-	0.95	1.7	1.15
Other Current Assets	2.45	2.35	2.75	6.12	6.67	2.48
Total Current Assets	21.66	27.06	18.45	17.54	43.04	55.3
Net Property, Plant & Equipment	3.73	4.4	2.54	1.98	0.52	0.03
Other Long-Term Assets	2.44	1.01	1.11	1.76	0.26	0.49
Total Assets	27.83	32.47	22.1	21.28	43.83	55.81
Accounts Payable	1.23	1.2	1.46	3.39	2.03	2.1
Accrued Expenses	0.53	0.73	3.04	2.89	10.89	3.14
Current Portion of Leases	1.2	2.1	0.55	0.47	0.4	0.27
Unearned Revenue	18.15	19.65	16.56	13.74	18.3	10.54
Other Current Liabilities	0.01	0.01	0	-	-	-
Total Current Liabilities	21.12	23.69	21.61	20.48	31.62	16.05
Long-Term Leases	0.42	0.56	0.75	0.94	0.09	-
Other Long-Term Liabilities	5.56	5.39	5.75	4.91	1	1
Total Long-Term Liabilities	5.97	5.95	6.5	5.85	1.09	1
Total Liabilities	27.09	29.63	28.11	26.33	32.71	17.05
Common Stock	0	0	0	0	0.01	0.01
Additional Paid-in Capital	192.8	191.95	169.71	166.55	152.53	149.03
Accumulated Other Comprehensive Income	-0.38	-0.42	-0.43	-0.36	-0.35	-0.15
Retained Earnings	-191.69	-188.69	-175.29	-171.24	-141.08	-110.13
Total Common Shareholders' Equity	0.73	2.84	-6.01	-5.05	11.11	38.75
Shareholders' Equity	0.73	2.84	-6.01	-5.05	11.11	38.75
Total Liabilities & Equity	27.83	32.47	22.1	21.28	43.83	55.81
Total Debt	1.61	2.66	1.3	1.4	0.49	0.27
Net Cash (Debt)	16.91	22.06	14.4	9.07	34.18	51.4
Net Cash Growth	-23.35%	53.21%	58.68%	-73.46%	-33.51%	1213.78%
Net Cash Per Share	1.34	1.97	1.69	1.25	4.85	10.09
Book Value	0.73	2.84	-6.01	-5.05	11.11	38.75
Book Value Per Share	0.06	0.25	-0.71	-0.69	1.58	7.60
Tangible Book Value	0.73	2.84	-6.01	-5.05	11.11	38.75
Tangible Book Value Per Share	0.06	0.25	-0.71	-0.69	1.58	7.60

SEC Filings: 10-K · 10-Q